Skip to main content

Table 5 The frequency of all grade toxicities in patients with GSTP1 wild type and mutants

From: Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

 

GSTP1 wild type (n = 70)

GSTP1 mutant (n = 34)

Toxicities

G 1–2

G 3–4

G 1–2

G 3–4

Hematological toxicity

 Anemia

31(29.8)

14(13.5)

15(14.4)

5(4.8)

 Leucopenia

35(33.7)

7(6.7)

13(12.5)

3(2.9)

 Neutropenia

30(28.8)

13(12.5)

9(8.7)

3(2.9)

 Thrombocytopenia

26(25.0)

8(7.7)

13(12.5)

4(3.8)

Gastrointestinal toxicity

 Mucositis

2(1.9)

7(6.7)

2(1.9)

2(1.9)

 Vomiting

22(21.2)

12(11.5)

5(4.8)

11(10.6)

 Diarrhea

8(7.7)

7(6.7)

4(3.8)

2(1.9)

Dermatology toxicity

 Skin ulceration

5(4.8)

1(0.9)

0(0)

3(2.9)

 Hand-foot skin reaction

8(7.7)

2(1.9)

3(2.9)

3(2.9)

  1. Data are presented as n (%)